FindMyKOL

Bartomeu Massutí

Enriched profile

Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante · Hospital General Universitario Doctor Balmis de Alicante

ORCID↗NPINone on file
✓ Itemized profile
RegionNot on fileSpecialtyMedical OncologyFocusLung Cancer Treatments and Mutations+4
Active KOLLatest publication2025Online presenceNone verifiedPaymentsNot attributedNIH fundingNone on fileWhy? →

Bartomeu Massutí is Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante at Hospital General Universitario Doctor Balmis de Alicante. OpenAlex indexes 390 publications with 20,658 citations (h-index 56); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 9 Nov 2026

Overview

Updated 14 Nov 2026

Bartomeu Massutí is Jefe del Servicio de Oncología Médica (Head of Medical Oncology), Hospital Doctor Balmis de Alicante at Hospital General Universitario Doctor Balmis de Alicante. The public record shows 390 publications with 20,658 citations (h-index 56), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 3 registered clinical trials.

  • Most recent indexed publication: 2025 · Oncoimmunology
  • Top research focus: Lung Cancer Treatments and Mutations
  • 3 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)2 trialsSmall Cell Lung Carcinoma2 trialsCarcinoma, Small Cell1 trialLung Diseases1 trialAcromegalyBreast CancerColorectal CancerCOVID-19Gastroesophageal CancerHead & Neck CancerHepatobiliary CancerHIVIdiopathic Pulmonary FibrosisLeukemia (AML/ALL/CML/CLL)LymphomaMelanomaOsteoporosisOvarian / Gynecologic CancerPancreatic CancerRheumatoid Arthritis

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesColorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Works with

trial sponsors and companies reporting payments
Fundación GECPClinical trials3Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
390publications

Publications indexed by OpenAlex, matched via ORCID. 3 in PubMed. Counts exclude supporting files.

20,658citations

Citations across these publications.

56h-index

H-index from these publications. i10-index 144.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 9 Nov 2026

131 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO, IASLC, ISPOR Europe per OpenAlex. The most recent:

All 131 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 9 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Editorial & leadership roles

journal and society appointments
  • Secretary

    Grupo Español de Cáncer de Pulmón (GECP)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →audible.com.au ↗

Secondary affiliations

appointments beyond the home institution
  • Profesor/a Asociado/a

    Medicina Clínica (Universidad Miguel Hernández, per UMH research portal; university not named on the page text)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →research.umh.es ↗

Media & interviews

press, podcasts and appearances
  • LungPod (GECP) Episode 4

    interview with Dr. Bartomeu Massuti

    2025
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →audible.com.au ↗
  • Interview in Alicante Plaza

    "Massutí, oncólogo: España está entre los primeros países en investigación de cáncer de pulmón"

    2023
    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alicanteplaza.es ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.